Immunogenicity and safety profile of the monovalent A/H1N1 MF59-adjuvanted vaccine in patients affected by cystic fibrosis
Alghisi, F., Palma, P., Montemitro, E., Bernardi, S., Pontrelli, G., Rossi, P., Lucidi, V.Volume:
66
Language:
english
Journal:
Thorax
DOI:
10.1136/thx.2010.156018
Date:
March, 2011
File:
PDF, 75 KB
english, 2011